Immunarray Ltd.

Company Summary

ImmunArray Ltd is an early commercial stage diagnostics company with the ability to rapidly develop new diagnostic tests using its proprietary iCHIP® technology The Company’s lead commercial product, SLE-key® is a blood test to assist the physician in ruling out Systemic Lupus Erythematosus

Transaction Overview

  • ImmunArray and Kindstar will undertake joint clinical testing of up to 500 serum samples from Chinese patients
  • Kindstar will acquire the exclusive rights to market ImmunArray’s SLE-Key Rule-Out® test in China

Significance of the Transaction

Support the clinical implementation of ImmunArray’s SLE-Key Rule-Out® test, which was introduced in the US in 2016 Combine the resources of two innovative diagnostic companies that are focused on finding solutions to the diagnosis of autoimmune diseases

Healthios Role

If you would like to learn more information about this transaction contact us below.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Immunarray Ltd.
Has entered into a strategic partnership with Kindstar Global
The undersigned acted as advisor to Immunarray
Read More